Environmental monitoring, product quality control, and mycoplasma testing of biopharmaceuticals require anaerobic bacteria monitoring. If the proper environment is not created when performing microbial testing, bacteria will not grow, and a possible contamination could be missed. Any bacterial contamination of biopharmaceutical products can have major negative effects on manufacturing, production costs, and profit margins.

A technology that relies on the evacuation and replacement of oxygen in a jar is valuable to the biopharmaceutical industry because it creates a quality-assured anaerobic environment within minutes. The Anoxomat system helps create anaerobic and custom environments that promote bacterial growth, essential to controlling the quality of biomanufacturing.

Just fill out this form to view the full PDF of this white paper.